Highly Selective Inhibitor Library

Catalog No. L2010

Highly selective inhibitors are able to specifically interact with the targeted molecule or pathway selectively with relatively little effect on other non-targeted molecules or pathway. The advantage of highly selective inhibitors over non-selective inhibitors is that they act more precisely on the target, thereby reducing interference with non-targets and reducing possible side-effects and toxicity. Highly selective inhibitors are widely used in drug development, especially in the treatment of cancer and other complex diseases, and are applied to intervene more effectively in pathological processes, improve the effectiveness of treatment, and reduce the incidence of adverse effects. TargetMol has collected 575 highly selective inhibitors, the vast majority of which are at least a hundred times more selective relative to other targets, making the Highly Selective Inhibitor Library an effective tool for drug development.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.